Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J3YX
|
|||
| Former ID |
DNCL003400
|
|||
| Drug Name |
BAY 86-6150
|
|||
| Synonyms |
Peg rFVIIa
Click to Show/Hide
|
|||
| Indication | Hemophilia [ICD-11: 3B10.0; ICD-10: D66-D68; ICD-9: 286] | Discontinued in Phase 2/3 | [1] | |
| Company |
Bayer HealthCare Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021847) | |||
| REF 2 | Bayer HealthCare and Maxygen Announce Hematology Agreement. U.S. Securities and Exchange Commission. July 2, 2008. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.